Author Search Results

Henagliflozin

Henagliflozin is a pharmaceutical drug for the treatment of type 2 diabetes. In China, it is approved for adult patients with type 2 diabetes to improve the glycemic control.

Henagliflozin, like other drugs of the gliflozin class, inhibits the transporter protein sodium/glucose cotransporter 2 (SGLT2) which leads to a reduction in blood glucose levels. Provided by Wikipedia

The effects of gradient running on lower limb skeletal muscle function parameters measured using TMG100 tensiomyography system

by Sek, Qin Rui
Published 2022

Get full text

Final Year Project

Data analysis on herbal treatment for early-stage chronic kidney disease patients with proteinuria in Singapore Thong Chai Medical Institution

by Lim, Rachel Qin Rui
Published 2022

Get full text

Final Year Project

High-harmonic generation in CdTe with ultra-low pump intensity and high photon flux

by Long, Zhe, Yang, Hang, Tian, Kan, He, Linzhen, Qin, Rui, Chen, Zi-Yu, Wang, Qi Jie, Liang, Houkun
Published 2023

Get full text

Article

Computational social systems for COVID-19 emergency management and beyond

by ZHANG, Jun Jason, WANG, Fei-Yue, YUAN, Yong, XU, Guandong, LIU, Huan, GAO, Wei, JAMEEL, Shoaib, RAZZAK, Imran, EKLUND, Peter, AHMED, Sheraz, QIN, Rui, LI, Juanjuan, WANG, Xiao, YANG, De-Nian, TURGUT, Damla, BENSLIMANE, Abderrahim, PRASAD, Neeli, CHEN, Kwang-Cheng
Published 2021

Get full text

text